Mirogabalin—A Novel Selective Ligand for the α2δ Calcium Channel Subunit

Mirogabalin—A Novel Selective Ligand for the α2δ Calcium Channel Subunit

The efficacy of neuropathic pain control remains unsatisfactory. Despite the availability of a variety of therapies, a significant proportion of patients suffer from poorly controlled pain of this kind. Consequently, new drugs and treatments are still being sought to remedy the situation. One such n...

Full description

Bibliographic Details
Main Authors: Renata Zajączkowska, Joanna Mika, Wojciech Leppert, Magdalena Kocot-Kępska, Małgorzata Malec-Milewska, Jerzy Wordliczek
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Pharmaceuticals
Subjects:
neuropathic pain
α2δ voltage-gated calcium channel subunit ligand
mirogabalin besylate
mechanism of action
pharmacodynamics
pharmacokinetics
Online Access:https://www.mdpi.com/1424-8247/14/2/112

Internet

https://www.mdpi.com/1424-8247/14/2/112

Similar Items